ABO Blood Group as a Model for Platelet Glycan Modification in Arterial Thrombosis
- 1 July 2015
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 35 (7), 1570-1578
- https://doi.org/10.1161/atvbaha.115.305337
Abstract
ABO blood groups have long been associated with cardiovascular disease, thrombosis, and acute coronary syndromes. Many studies over the years have shown type O blood group to be associated with lower risk of cardiovascular disease than non–type O blood groups. However, the mechanisms underlying this association remain unclear. Although ABO blood group is associated with variations in concentrations of circulating von Willebrand Factor and other endothelial cell adhesion molecules, ABO antigens are also present on several platelet surface glycoproteins and glycosphingolipids. As we highlight in this platelet-centric review, these glycomic modifications may affect platelet function in arterial thrombosis. More broadly, improving our understanding of the role of platelet glycan modifications in acute coronary syndromes may inform future diagnostics and therapeutics for cardiovascular diseases.Keywords
This publication has 77 references indexed in Scilit:
- A serotonin-induced N-glycan switch regulates platelet aggregationScientific Reports, 2013
- Platelet biogenesis and functions require correct protein O-glycosylationProceedings of the National Academy of Sciences of the United States of America, 2012
- Large-scale association analysis identifies 13 new susceptibility loci for coronary artery diseaseNature Genetics, 2011
- Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studiesThe Lancet, 2011
- ABO blood group alleles: A risk factor for coronary artery disease. An angiographic studyAtherosclerosis, 2010
- Biological, clinical and population relevance of 95 loci for blood lipidsNature, 2010
- Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levelsHuman Molecular Genetics, 2010
- Genome-Wide Association Identifies the ABO Blood Group as a Major Locus Associated With Serum Levels of Soluble E-SelectinArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- The Ashwell receptor mitigates the lethal coagulopathy of sepsisNature Medicine, 2008
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002